Cargando…
IL‐2 modulates Th2 cell responses to glucocorticosteroid: A cause of persistent type 2 inflammation?
BACKGROUND: Glucocorticosteroids (GCs) are the main treatment for asthma as they reduce type 2 cytokine expression and induce apoptosis. Asthma severity is associated with type 2 inflammation, circulating Th2 cells and higher GC requirements. OBJECTIVE: The aim of this study was to assess whether ex...
Autores principales: | Kanagalingam, Tharsan, Solomon, Lauren, Vijeyakumaran, Meerah, Palikhe, Nami Shrestha, Vliagoftis, Harissios, Cameron, Lisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688076/ https://www.ncbi.nlm.nih.gov/pubmed/30994266 http://dx.doi.org/10.1002/iid3.249 |
Ejemplares similares
-
Comparative efficacy of glucocorticoid receptor agonists on Th2 cell function and attenuation by progesterone
por: Luchak, Alexander, et al.
Publicado: (2020) -
Interleukin‐25 initiates Th2 differentiation of human CD4(+) T cells and influences expression of its own receptor
por: Bredo, Graeme, et al.
Publicado: (2015) -
Protease-activated receptor-2: Role in asthma pathogenesis and utility as a biomarker of disease severity
por: Gandhi, Vivek Dipak, et al.
Publicado: (2022) -
The CRTh2 polymorphism rs533116 G > A associates with asthma severity in older females
por: Shrestha Palikhe, Nami, et al.
Publicado: (2022) -
Proteinase-activated receptor-2 (PAR-2) expression on inflammatory cells in severe asthma
por: Nahirney, Drew, et al.
Publicado: (2014)